Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target DUSP1

doi:10.3748/wjg.v24.i5.573

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8631)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

469

WORD

231

HTML

4670

Figures (1-6)

289

Tables (1-3)

255

Sum=5914

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1118

Download

1599

Sum=2717

Feb 7, 2018 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Feb 7, 2018; 24(5): 573-582
Published online Feb 7, 2018. doi: 10.3748/wjg.v24.i5.573

Full Size Figure Download Figure

Figure 6 The possible role of miR-202-3p/DUSP1 in the pathogenesis of type 1 g-NETs.

Citation: Dou D, Shi YF, Liu Q, Luo J, Liu JX, Liu M, Liu YY, Li YL, Qiu XD, Tan HY. Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target DUSP1. World J Gastroenterol 2018; 24(5): 573-582
URL: https://www.wjgnet.com/1007-9327/full/v24/i5/573.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i5.573